Spotify Technology S.A. Releases Financial Results for Second Quarter 2023
Spotify Technology S.A. (NYSE: SPOT) has released its financial results for the second quarter of 2023 today. Please visit investors.spotify.com to view the Shareholder Deck and other supplemental materials.
As previously announced, the company will host a live question and answer session to discuss second quarter 2023 financial results at 8:00 a.m. Eastern Time. Daniel Ek, our Founder and Chief Executive Officer, and Paul Vogel, our Chief Financial Officer, will be on hand to answer questions submitted through slido.com using the event code #SpotifyEarningsQ223.
A live webcast of the earnings call will be accessible at investors.spotify.com and a recording of the webcast will be available following the session.
About Spotify Technology S.A.
Spotify's platform revolutionized music listening forever when we launched in 2008. Today, more listeners than ever can discover, manage and enjoy over 100 million tracks, 5 million podcasts titles, and 350,000 audiobooks on Spotify. We are the world's most popular audio streaming subscription service with more than 551 million users, including 220 million subscribers across 184 markets.
China and Kazakhstan have always supported each other and have always been partners in times of challenges, Chinese President Xi Jinping said in a signed article in the Kazakhstanskaya Pravda newspaper and Kazinform International News Agency on...
H.I.G. Capital ("H.I.G."), a leading global alternative investment firm with $64 billion of capital under management, is pleased to announce that an affiliate has signed a definitive agreement to acquire CGH Group S.A. ("CGH" or the "Company"), a...
Truecaller, the leading global platform for verifying contacts and blocking unwanted communication, is publishing its interim report for January-June on Friday 19 July 2024 at 07.30 CET.
Alan Mamedi, CEO and Odd Bolin, CFO presents the report and...
Calliditas Therapeutics AB (STO: CALTX) ("Calliditas") today announces that its partner Viatris Pharmaceutical Japan G.K. ("Viatris") has initiated a phase III clinical trial in Japan with Nefecon, named VR-205 in the Japanese market, in Japanese...
China and Kazakhstan have always supported each other and have always been partners in times of challenges, Chinese President Xi Jinping said in a signed article in the Kazakhstanskaya Pravda newspaper and Kazinform International News Agency on...